148 related articles for article (PubMed ID: 10811058)
1. Decreased plasma concentrations of L-hydroxy-arginine as a marker of reduced NO formation in patients with combined cardiovascular risk factors.
Garlichs CD; Beyer J; Zhang H; Schmeisser A; Plötze K; Mügge A; Schellong S; Daniel WG
J Lab Clin Med; 2000 May; 135(5):419-25. PubMed ID: 10811058
[TBL] [Abstract][Full Text] [Related]
2. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
Selley ML
J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
[TBL] [Abstract][Full Text] [Related]
3. L-Arginine-nitric oxide pathway-related metabolites in the aqueous humor of diabetic patients.
Hattenbach LO; Allers A; Klais C; Koch F; Hecker M
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):213-7. PubMed ID: 10634623
[TBL] [Abstract][Full Text] [Related]
4. Impaired L-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects.
Schlaich MP; Parnell MM; Ahlers BA; Finch S; Marshall T; Zhang WZ; Kaye DM
Circulation; 2004 Dec; 110(24):3680-6. PubMed ID: 15569830
[TBL] [Abstract][Full Text] [Related]
5. Plasma amino acid profile and L-arginine uptake in red blood cells from malnourished uremic patients.
Reis PF; da Silva CD; Brunini TM; Moss MB; Siqueira MA; Santos SF; Roberts NB; Ellory JC; Mann GE; Mendes-Ribeiro AC
J Ren Nutr; 2006 Oct; 16(4):325-31. PubMed ID: 17046616
[TBL] [Abstract][Full Text] [Related]
6. L-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients.
Cassone Faldetta M; Laurenti O; Desideri G; Bravi MC; De Luca O; Marinucci MC; De Mattia G; Ferri C
Diabetologia; 2002 Aug; 45(8):1120-7. PubMed ID: 12189442
[TBL] [Abstract][Full Text] [Related]
7. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline.
Smith HA; Canter JA; Christian KG; Drinkwater DC; Scholl FG; Christman BW; Rice GD; Barr FE; Summar ML
J Thorac Cardiovasc Surg; 2006 Jul; 132(1):58-65. PubMed ID: 16798303
[TBL] [Abstract][Full Text] [Related]
9. Metabolites of the L-arginine-NO pathway in patients with left-to-right shunt.
Gorenflo M; Zheng C; Pöge A; Bettendorf M; Werle E; Fiehn W; Ulmer HE
Clin Lab; 2001; 47(9-10):441-7. PubMed ID: 11596905
[TBL] [Abstract][Full Text] [Related]
10. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals.
Miller AL
Altern Med Rev; 2006 Mar; 11(1):23-9. PubMed ID: 16597191
[TBL] [Abstract][Full Text] [Related]
11. Assessment of nitric oxide production by measurement of [15N]citrulline enrichment in human plasma using high-performance liquid chromatography-mass spectrometry.
Lagerwerf FM; Wever RM; van Rijn HJ; Versluis C; Heerma W; Haverkamp J; Koomans HA; Rabelink TJ; Boer P
Anal Biochem; 1998 Mar; 257(1):45-52. PubMed ID: 9512771
[TBL] [Abstract][Full Text] [Related]
12. Reduced citrulline availability by OTC deficiency in mice is related to reduced nitric oxide production.
Luiking YC; Hallemeesch MM; van de Poll MC; Dejong CH; de Jonge WJ; Lamers WH; Deutz NE
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1315-22. PubMed ID: 18697914
[TBL] [Abstract][Full Text] [Related]
13. Diminished L-arginine bioavailability in hypertension.
Moss MB; Brunini TM; Soares De Moura R; Novaes Malagris LE; Roberts NB; Ellory JC; Mann GE; Mendes Ribeiro AC
Clin Sci (Lond); 2004 Oct; 107(4):391-7. PubMed ID: 15182236
[TBL] [Abstract][Full Text] [Related]
14. Decreased hepatic nitric oxide synthesis during liver surgery.
Ueda T; Sakabe T; Oka M; Maeda Y; Nishida M; Murakami F; Maekawa T
Hepatogastroenterology; 1999; 46(27):1917-22. PubMed ID: 10430369
[TBL] [Abstract][Full Text] [Related]
15. Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature?
Schlaich MP; Jacobi J; John S; Delles C; Fleischmann I; Schmieder RE
Clin Sci (Lond); 2000 Oct; 99(4):293-302. PubMed ID: 10995594
[TBL] [Abstract][Full Text] [Related]
16. L-arginine plasma levels and severity of idiopathic pulmonary arterial hypertension.
Beyer J; Kolditz M; Ewert R; Rubens C; Opitz C; Schellong S; Hoeffken G; Halank M
Vasa; 2008 Feb; 37(1):61-7. PubMed ID: 18512543
[TBL] [Abstract][Full Text] [Related]
17. Arginine, citrulline and nitric oxide metabolism in sepsis.
Kao CC; Bandi V; Guntupalli KK; Wu M; Castillo L; Jahoor F
Clin Sci (Lond); 2009 Jun; 117(1):23-30. PubMed ID: 19105791
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension.
de Meirelles LR; Mendes-Ribeiro AC; Santoro MM; Mendes MA; da Silva MN; Mann GE; Brunini TM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1267-71. PubMed ID: 17973865
[TBL] [Abstract][Full Text] [Related]
19. Formation of N delta-cyanoornithine from NG-hydroxy-L-arginine and hydrogen peroxide by neuronal nitric oxide synthase: implications for mechanism.
Clague MJ; Wishnok JS; Marletta MA
Biochemistry; 1997 Nov; 36(47):14465-73. PubMed ID: 9398165
[TBL] [Abstract][Full Text] [Related]
20. Hypocitrullinemia in patients with MELAS: an insight into the "MELAS paradox".
Naini A; Kaufmann P; Shanske S; Engelstad K; De Vivo DC; Schon EA
J Neurol Sci; 2005 Mar; 229-230():187-93. PubMed ID: 15760638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
